HealthEquity - HQY Stock Forecast, Price & News

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 1 sell rating, 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HQY shares.
View HQY analyst ratings or view top-rated stocks.

12 Wall Street analysts have issued 1 year price objectives for HealthEquity's shares. Their HQY share price forecasts range from $56.00 to $95.00. On average, they expect the company's share price to reach $73.77 in the next year. This suggests a possible upside of 15.1% from the stock's current price.
View analysts price targets for HQY or view top-rated stocks among Wall Street analysts.

HealthEquity's stock was trading at $44.24 at the start of the year. Since then, HQY shares have increased by 44.8% and is now trading at $64.08.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, December 5th 2022.
View our HQY earnings forecast.

HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings data on Tuesday, September, 6th. The company reported $0.33 EPS for the quarter, meeting the consensus estimate of $0.33. HealthEquity had a positive trailing twelve-month return on equity of 3.03% and a negative net margin of 7.11%. During the same quarter last year, the firm posted $0.21 EPS.

HealthEquity issued an update on its FY 2023 earnings guidance on Tuesday, September, 6th. The company provided EPS guidance of $1.23-$1.32 for the period, compared to the consensus EPS estimate of $1.28. The company issued revenue guidance of $834.00 million-$844.00 million, compared to the consensus revenue estimate of $831.91 million.

197 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

HealthEquity's stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (4.25%), William Blair Investment Management LLC (3.19%), State Street Corp (3.08%), JPMorgan Chase & Co. (2.91%), Mackenzie Financial Corp (2.43%) and Brown Advisory Inc. (2.09%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker and William Robert Otten.
View institutional ownership trends.

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HQY stock can currently be purchased for approximately $64.08.

HealthEquity (NASDAQ:HQY) has a market capitalization of $5.41 billion and generates $756.56 million in revenue each year. The company earns $-44,290,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis.

The company employs 3,695 workers across the globe.

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The official website for the company is www.healthequity.com. The company can be reached via phone at (801) 727-1000, via email at rputnam@healthequity.com, or via fax at 801-727-1005.